Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase

被引:245
作者
Ben-Shlomo, Shani [1 ]
Zvibel, Isabel [1 ]
Shnell, Mati
Shlomai, Amir [1 ]
Chepurko, Elena [1 ]
Halpern, Zamir [1 ]
Barzilai, Nir [2 ]
Oren, Ran [1 ]
Fishman, Sigal [1 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Sackler Sch Med, Dept Gastroenterol & Hepatol, IL-64239 Tel Aviv, Israel
[2] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA
关键词
Glucagon-like peptide 1; Dipeptidylpetidase; 4; Liver; Lipogenesis; Gluconeogenesis; Incretins; AMPK; Inflammatory cytokines; INDUCED INSULIN-RESISTANCE; TISSUE GROWTH-FACTOR; LIVER; RAT; STEATOSIS; HEPATOCYTES; METFORMIN; GLP-1; IV; GLUCONEOGENESIS;
D O I
10.1016/j.jhep.2010.09.032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Glucagon-like peptide-1 (GLP-1), a gut-derived peptide degraded by dipeptidyl peptidase-4 (DPP4), stimulates insulin secretion in response to nutrients, yet its direct effect on the liver is controversial. We investigated the effects of GLP-1 on hepatic fat and glucose metabolism and elucidated its mechanism of action. Methods: Hepatic fat metabolism, including lipogenic enzymes and signal transduction regulators, was assessed in livers of DPP4-deficient rats (DPP4-) with chronically elevated GLP-1 and in GLP-1-treated primary hepatocytes. The effect of chronic elevated GLP-1 on insulin sensitivity was measured using the hyperinsulinemic-euglycemic clamp. Results: Normal and high fat diet fed DPP4-rats displayed reduced hepatic triglycerides, accompanied by down-regulation of lipogenesis enzymes and parallel up-regulation of carnitine palmitoyltransferase-1, a key enzyme in fatty acid beta-oxidation. In vitro studies demonstrated that these effects were directly induced by GLP-1. Mechanistically, GLP-1 increased cAMP in hepatocytes, resulting in the phosphorylation of cAMP-activated protein kinase (AMPK), a suppressor of lipogenesis. Indeed, hepatocytes expressing a dominant negative Ad-DN-AMPK displayed attenuated GLP-1 effects on AMPK phosphorylation and its downstream lipogenic targets. Importantly, normoglycemic DPP4-rats did not display improved hepatic insulin sensitivity in vivo, suggesting a direct effect of GLP-1 on fat metabolism. Finally, DPP4-rats expressed lower levels of hepatic proinflammatory and profibrotic cytokines in response to nutrient stimuli. Conclusions: GLP-1 suppresses hepatic lipogenesis via activation of the AMPK pathway. GLP-1 inhibitory effects on hepatic fat accumulation and nutrient-induced hepatic proinflammatory response suggest GLP-1 analogs as novel therapies for nonalcoholic fatty liver diseases. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1214 / 1223
页数:10
相关论文
共 32 条
  • [1] Biology of incretins: GLP-1 and GIP
    Baggio, Laurie L.
    Drucker, Daniel J.
    [J]. GASTROENTEROLOGY, 2007, 132 (06) : 2131 - 2157
  • [2] HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS - A BIOCHEMICAL AND FINE STRUCTURAL STUDY
    BERRY, MN
    FRIEND, DS
    [J]. JOURNAL OF CELL BIOLOGY, 1969, 43 (03) : 506 - +
  • [3] Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium
    Block, GD
    Locker, J
    Bowen, WC
    Petersen, BE
    Katyal, S
    Strom, SC
    Riley, T
    Howard, TA
    Michalopoulos, GK
    [J]. JOURNAL OF CELL BIOLOGY, 1996, 132 (06) : 1133 - 1149
  • [4] Cyclic AMP and fatty acids increase carnitine palmitoyltransferase I gene transcription in cultured fetal rat hepatocytes
    Chatelain, F
    Kohl, C
    Esser, V
    McGarry, JD
    Girard, J
    Pegorier, JP
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 235 (03): : 789 - 798
  • [5] Interleukin-10 is a protective factor against diet-induced insulin resistance in liver
    Cintra, Dennys E.
    Pauli, Jose R.
    Araujo, Eliana P.
    Moraes, Juliana C.
    de Souza, Claudio T.
    Milanski, Marciane
    Morari, Joseane
    Gambero, Alessandra
    Saad, Mario J.
    Velloso, Licio A.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (04) : 628 - 637
  • [6] Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
    Conarello, SL
    Li, ZH
    Ronan, J
    Roy, RS
    Zhu, L
    Jiang, GQ
    Liu, F
    Woods, J
    Zycband, E
    Moller, DE
    Thornberry, NA
    Zhang, BB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6825 - 6830
  • [7] Effects of glucagon-like peptide 1 on the hepatic glucose metabolism
    D'Alessio, D
    Vahl, T
    Prigeon, R
    [J]. HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 837 - 841
  • [8] Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
    Ding, XK
    Saxena, NK
    Lin, SB
    Gupta, N
    Anania, FA
    [J]. HEPATOLOGY, 2006, 43 (01) : 173 - 181
  • [9] Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice
    Flock, Grace
    Baggio, Laurie L.
    Longuet, Christine
    Drucker, Daniel J.
    [J]. DIABETES, 2007, 56 (12) : 3006 - 3013
  • [10] Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cells
    Goto, Megumi
    Murakawa, Masao
    Kadoshima-Yamaoka, Kumiko
    Tanaka, Yoshitaka
    Inoue, Hidekazu
    Murafuji, Hidenobu
    Hayashi, Yasuhiro
    Miura, Kenju
    Nakatsuka, Takashi
    Nagahira, Kazuhiro
    Chamoto, Kenji
    Fukuda, Yoshiaki
    Nishimura, Takashi
    [J]. CELLULAR IMMUNOLOGY, 2009, 258 (02) : 147 - 151